| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |